Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.

PURPOSE:To investigate the prognostic value of cavernoussinus invasion (CSI) in patients with nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiotherapy (IMRT). PATIENTS AND METHODS:Retrospective review of data from 1,087 patients with biopsy-proven, non-metastatic NPC. All patient...

Full description

Bibliographic Details
Main Authors: Jun-Fang Liao, Li Ma, Xiao-Jing Du, Mei Lan, Ying Guo, Lie Zheng, Yun-Fei Xia, Wei Luo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4732613?pdf=render
_version_ 1818369928107917312
author Jun-Fang Liao
Li Ma
Xiao-Jing Du
Mei Lan
Ying Guo
Lie Zheng
Yun-Fei Xia
Wei Luo
author_facet Jun-Fang Liao
Li Ma
Xiao-Jing Du
Mei Lan
Ying Guo
Lie Zheng
Yun-Fei Xia
Wei Luo
author_sort Jun-Fang Liao
collection DOAJ
description PURPOSE:To investigate the prognostic value of cavernoussinus invasion (CSI) in patients with nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiotherapy (IMRT). PATIENTS AND METHODS:Retrospective review of data from 1,087 patients with biopsy-proven, non-metastatic NPC. All patients were diagnosed using magnetic resonance imaging (MRI) scans and received IMRT as the primary treatment. RESULTS:The incidence of cavernoussinus invasion in this cohort was 12.1%. In univariate analysis, 5-year overall survival (OS) (70.6% vs. 88.5%, P < 0.001) and distant metastasis-free survival (DMFS) (71.4% vs. 87.7%, P < 0.001), but not locoregional relapse-free survival (LRFS) (93.9% vs. 93.7%, P = 0.341), were significantly different between patients with and without cavernoussinus invasion. In the T4 subgroup, the 5-year OS, DMFS, and LRFS of patients with and without cavernoussinus extension were 70.6% vs. 81.9% (P = 0.011), 71.4% vs. 84.1% (P = 0.011), and 91.2% vs. 89.7% (P = 0.501), respectively. In multivariate analysis, cavernoussinus invasion was an independent prognostic factor for poorer OS (HR = 1.782; P = 0.013) and DMFS (HR = 1.771; P = 0.016), but not LRFS (HR = 0.632; P = 0.294). In patients with lymph node metastasis, the DMFS rates of patients with and without cavernoussinus invasion were significantly different (P < 0.001). Preliminaryanalysis indicated that neoadjuvant chemotherapy led to better DMFS and OS in patients with cavernoussinus invasion than concurrent chemotherapy or radiotherapy alone; however, the differences were not significant. CONCLUSIONS:In the IMRT era, cavernoussinus invasion remains a prognostic factor for poor DMFS and OS in NPC, even in patients with T4 disease.
first_indexed 2024-12-13T23:31:38Z
format Article
id doaj.art-20f1797896af4a03bdbe1e0331586a8f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T23:31:38Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-20f1797896af4a03bdbe1e0331586a8f2022-12-21T23:27:24ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01111e014678710.1371/journal.pone.0146787Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.Jun-Fang LiaoLi MaXiao-Jing DuMei LanYing GuoLie ZhengYun-Fei XiaWei LuoPURPOSE:To investigate the prognostic value of cavernoussinus invasion (CSI) in patients with nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiotherapy (IMRT). PATIENTS AND METHODS:Retrospective review of data from 1,087 patients with biopsy-proven, non-metastatic NPC. All patients were diagnosed using magnetic resonance imaging (MRI) scans and received IMRT as the primary treatment. RESULTS:The incidence of cavernoussinus invasion in this cohort was 12.1%. In univariate analysis, 5-year overall survival (OS) (70.6% vs. 88.5%, P < 0.001) and distant metastasis-free survival (DMFS) (71.4% vs. 87.7%, P < 0.001), but not locoregional relapse-free survival (LRFS) (93.9% vs. 93.7%, P = 0.341), were significantly different between patients with and without cavernoussinus invasion. In the T4 subgroup, the 5-year OS, DMFS, and LRFS of patients with and without cavernoussinus extension were 70.6% vs. 81.9% (P = 0.011), 71.4% vs. 84.1% (P = 0.011), and 91.2% vs. 89.7% (P = 0.501), respectively. In multivariate analysis, cavernoussinus invasion was an independent prognostic factor for poorer OS (HR = 1.782; P = 0.013) and DMFS (HR = 1.771; P = 0.016), but not LRFS (HR = 0.632; P = 0.294). In patients with lymph node metastasis, the DMFS rates of patients with and without cavernoussinus invasion were significantly different (P < 0.001). Preliminaryanalysis indicated that neoadjuvant chemotherapy led to better DMFS and OS in patients with cavernoussinus invasion than concurrent chemotherapy or radiotherapy alone; however, the differences were not significant. CONCLUSIONS:In the IMRT era, cavernoussinus invasion remains a prognostic factor for poor DMFS and OS in NPC, even in patients with T4 disease.http://europepmc.org/articles/PMC4732613?pdf=render
spellingShingle Jun-Fang Liao
Li Ma
Xiao-Jing Du
Mei Lan
Ying Guo
Lie Zheng
Yun-Fei Xia
Wei Luo
Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
PLoS ONE
title Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
title_full Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
title_fullStr Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
title_full_unstemmed Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
title_short Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
title_sort prognostic value of cavernous sinus invasion in patients with nasopharyngeal carcinoma treated with intensity modulated radiotherapy
url http://europepmc.org/articles/PMC4732613?pdf=render
work_keys_str_mv AT junfangliao prognosticvalueofcavernoussinusinvasioninpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT lima prognosticvalueofcavernoussinusinvasioninpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT xiaojingdu prognosticvalueofcavernoussinusinvasioninpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT meilan prognosticvalueofcavernoussinusinvasioninpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT yingguo prognosticvalueofcavernoussinusinvasioninpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT liezheng prognosticvalueofcavernoussinusinvasioninpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT yunfeixia prognosticvalueofcavernoussinusinvasioninpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy
AT weiluo prognosticvalueofcavernoussinusinvasioninpatientswithnasopharyngealcarcinomatreatedwithintensitymodulatedradiotherapy